Publications by authors named "Almuth Meyer"

Claim this Profile
T
The rate of postoperative hematoma following risk-adapted cessation of oral anticoagulation in patients undergoing endoscopic endonasal surgery for pituitary adenomas.
Denise Loeschner, Andrei Enciu, Prajjwal Raj Wagle, Anna Jung, Geralf Kellner, Almuth Meyer

Acta Neurochir (Wien)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and risk of postoperative bleeding in patients with low-dose antiplatelet aspirin medication during endoscopic endonasal surgery for pituitary adenomas.
Andrei Enciu, Denise Loeschner, Mahmoud Alhallak, Geralf Kellner, Almuth Meyer

Acta Neurochir (Wien)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two- and three-dimensional endoscopic endonasal surgery of large and giant pituitary adenomas-outcome analysis of a series of 62 patients from a single pituitary center.
Denise Loeschner, Andrei Enciu, Geralf Kellner, Almuth Meyer, Henri Wallaschofski

Neurosurg Rev· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous rhPTH (1-34) treatment in chronic hypoparathyroidism.
Carmina Teresa Fuss, Stephanie Burger-Stritt, Silke Horn, Ann-Cathrin Koschker, Kathrin Frey, Almuth Meyer

Endocrinol Diabetes Metab Case Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic Endonasal Surgery for Removal of Pituitary Adenomas: A Surgical Case Series of Treatment Results Using Different 2- and 3-Dimensional Visualization Systems.
Shefqet Hajdari, Geralf Kellner, Almuth Meyer, Steffen Rosahl, Ruediger Gerlach

World Neurosurg· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Birke Bausch, Francesca Schiavi, Ying Ni, Jenny Welander, Attila Patocs, Almuth Meyer

JAMA Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of acromegaly patients with risk-adapted single or fractionated stereotactic high-precision radiotherapy: High local control and low toxicity in a pooled series.
Jan Patrick Boström, Thomas Kinfe, Almuth Meyer, Bogdan Pintea, Rüdiger Gerlach

Strahlenther Onkol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted single or fractionated stereotactic high-precision radiotherapy in a pooled series of nonfunctioning pituitary adenomas: high local control and low toxicity.
Jan Patrick Boström, Almuth Meyer, Bogdan Pintea, Rüdiger Gerlach, Gunnar Surber

Strahlenther Onkol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis